BioTechne Corp (TECH)
(Delayed Data from NSDQ)
$51.52 USD
-0.26 (-0.50%)
Updated Sep 17, 2025 04:00 PM ET
After-Market: $51.53 +0.01 (0.02%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth A Momentum B VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
TECH 51.52 -0.26(-0.50%)
Will TECH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TECH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TECH
Here's What Key Metrics Tell Us About Techne (TECH) Q4 Earnings
Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls
TECH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Techne (TECH) Beats Q4 Earnings and Revenue Estimates
Bio-Techne Q4 Earnings Preview: What's in Store for the Stock?
INCY or TECH: Which Is the Better Value Stock Right Now?
Other News for TECH
Tesla To Redesign Electronic Door Handles Amid NHTSA Probe Into Possible Safety Risk
Tesla Robotaxi Rival Waymo Reaches 96 Million Driverless Miles As Robotaxi Race Heats Up
Lyft Finds Its Robotaxi Mojo—But Uber's Still In The Fast Lane
Meta Connect Preview: How To Watch Mark Zuckerberg Speech, What's Next For AI, Smart Glasses & Metaverse
Elon Musk Says Future Of Public Transport Is 'Individualized' Autonomous EVs: 'You Can't Have 3D Buildings...'